Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

PCR services are basis of new Exiqon, AROS agreement
October 2011
SHARING OPTIONS:

WOBURN, Mass.Exiqon A/S and AROS Applied Biotechnology A/S recently signed a Center of Excellence agreement by which AROS will gain the ability to provide real-time PCR services based on Exiqon's miRCURY LNA Universal RT microRNA PCR product line. The agreement leverages Exiqon's and AROS' positions as leaders in the supply of high-value gene expression analysis products and total genomic solutions services, respectively. Additionally, LNA-based microRNA profiling has significant potential as a non-invasive method of discovering new biomarkers, since including LNA in the PCR primers adds a sensitivity that makes it possible to profile non-invasive samples, such as serum or plasma, with a very low quantity of RNA. Brian Sorensen, CEO of AROS, said the company is "convinced that Exiqon's miRCURY LNA Universal RT microRNA PCR product line is a strong addition to our offering."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.